Te‐Chun Hsia
Impact in
-
- Lung Cancer Treatments and Mutations
- Pleural and Pulmonary Diseases
- Lung Cancer Diagnosis and Treatment
- Toxicology top 1%
Papers in
-
- Lung Cancer Treatments and Mutations 23
- Lung Cancer Diagnosis and Treatment 11
- Pleural and Pulmonary Diseases 6
-
- Genomics, phytochemicals, and oxidative stress 6
- Co-authors
- Jing‐Gung Chung (34 shared papers)Chih‐Yen Tu (39 shared papers)Jai‐Sing Yang (16 shared papers)Wu-Huei Hsu (30 shared papers)Chuen-Ming Shih (23 shared papers)Chia‐Hung Chen (24 shared papers)Hung‐Jen Chen (12 shared papers)Hsu-Feng Lu (6 shared papers)
- Journals
- Journal of Thoracic Oncology (9 papers)PLoS ONE (7 papers)Anticancer Research (7 papers)Medicine (5 papers)Environmental Toxicology (5 papers)
- Partner nations
- TaiwanUnited StatesChina
In The Last Decade
Te‐Chun Hsia
129 papers receiving 4.3k citations
Te‐Chun Hsia's Hit Papers
Peers
Comparison fields: 5 of 127
- Pulmonary and Respiratory Medicine 1.4k
- Toxicology 143
- Critical Care and Intensive Care Medicine 183
- Oncology 967
- Cancer Research 499
Countries citing papers authored by Te‐Chun Hsia
This map shows the geographic impact of Te‐Chun Hsia's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Te‐Chun Hsia with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Te‐Chun Hsia more than expected).
Fields of papers citing papers by Te‐Chun Hsia
This network shows the impact of papers produced by Te‐Chun Hsia. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Te‐Chun Hsia. The network helps show where Te‐Chun Hsia may publish in the future.
Co-authors
The 25 scholars most cited alongside Te‐Chun Hsia, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 132 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Afatinib for patients with lung adenocarcinoma and epidermal growth factor receptor mutations (LUX-Lung 2): a phase 2 trial Hit paper breakdown → | 2012 | 334 |
| 2 | 2019 | 289 | |
| 3 | 2010 | 188 | |
| 4 | 2015 | 186 | |
| 5 | 2010 | 172 | |
| 6 | 2005 | 142 | |
| 7 | 2008 | 107 | |
| 8 | 2011 | 85 | |
| 9 | 2008 | 85 | |
| 10 | 2017 | 79 | |
| 11 | 2016 | 77 | |
| 12 | Suppression of cell invasion and migration by propofol are involved in down-regulating matrix metalloproteinase-2 and p38 MAPK signaling in A549 human lung adenocarcinoma epithelial cells. | 2012 | 68 |
| 13 | 2004 | 65 | |
| 14 | 2019 | 63 | |
| 15 | 2011 | 61 | |
| 16 | 2021 | 61 | |
| 17 | 2013 | 61 | |
| 18 | 2018 | 59 | |
| 19 | 2010 | 57 | |
| 20 | 2014 | 56 |
About Te‐Chun Hsia
Te‐Chun Hsia is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology, Oncology, Cancer Research and Plant Science, having authored 132 papers that have together received 4.4k indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (23 papers), Lung Cancer Diagnosis and Treatment (11 papers), Bioactive Compounds and Antitumor Agents (10 papers), Lung Cancer Research Studies (10 papers), Genomics, phytochemicals, and oxidative stress (6 papers), Pleural and Pulmonary Diseases (6 papers), Colorectal Cancer Treatments and Studies (5 papers) and Phytochemistry and biological activity of medicinal plants (5 papers). The work is most often cited by research in Pulmonary and Respiratory Medicine (1.4k citations), Toxicology (143 citations), Critical Care and Intensive Care Medicine (183 citations), Oncology (967 citations) and Cancer Research (499 citations). Te‐Chun Hsia has collaborated with scholars based in Taiwan, United States and China. Frequent co-authors include Jing‐Gung Chung, Chih‐Yen Tu, Jai‐Sing Yang, Wu-Huei Hsu, Chuen-Ming Shih, Chia‐Hung Chen, Hung‐Jen Chen, Hsu-Feng Lu, Wei‐Chih Liao and Chao-Lin Kuo. Their work appears in journals such as Journal of Thoracic Oncology, PLoS ONE, Anticancer Research, Medicine and Environmental Toxicology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.